CSI Market
Sign In | Register

Spyglass Pharma Inc (SGP) Annual Income Statement

Annual · GAAP · USD millions
Access SGP quarterly income statements →
The data below summarizes Spyglass Pharma Inc's income statement results from FY 2005 to Dec 31 2025, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(FY 2008) (FY 2007) (FY 2006) (FY 2005)
Revenues
Net revenues0.00
Total Revenue0.00
Costs & Expenses
Cost of Goods and Services Sold0.00
Gross Profit0.00
Selling, Administration, Marketing12.27
Research and Development Expense29.18
Other exp. /-income0.00
Special Items0.00
Total operating costs including COS41.45
Operating income / -loss-41.45
Net Interest (-)Expense / Income0.00
Investment Income, Interest-3.11
Income from affiliates0.00
Other loss/ -income1.53
Total costs & expenses39.87
Income & Taxes
Income / -loss before income taxes-39.87
Income taxes expenses / -benefit0.00
Income after income taxes-39.87
Income / -loss from continuing operations-39.87
Preferred dividends0.00
Net income / -loss-39.87
Income / -loss to shareholder-39.87
EBIT-39.87
EBITD-39.26
EBITDA-39.26
Earnings Per Share
Basic EPS (excl. extra items)-17.98
Basic Net EPS-17.98
Basic shares outstanding (Mill. of Units)22.17
Diluted Net EPS-17.98
Diluted average shares (Mill. of Units)22.17
Dividend per share0.00
4 historic quarters locked

Sign in to unlock the full Spyglass Pharma Inc income statement history.

Sign In Create Free Account

About Spyglass Pharma Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: March 26, 2026
  • Original filing: sgp-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.